An autonomous tumor-targeted nanoprodrug for reactive oxygen species-activatable dual-cytochrome c/doxorubicin antitumor therapy
文献类型:期刊论文
作者 | Pei, Yuxia1; Li, Menghuan2; Hou, Yanhua3; Hu, Yan1; Chu, Guangyu4; Dai, Liangliang1; Li, Ke1; Xing, Yuxin1; Tao, Bailong1; Yu, Yonglin1 |
刊名 | NANOSCALE
![]() |
出版日期 | 2018-06-28 |
卷号 | 10期号:24页码:11418-11429 |
ISSN号 | 2040-3364 |
DOI | 10.1039/c8nr02358a |
英文摘要 | The precise tumor cell-specific delivery of therapeutic proteins and the elimination of side effects associated with routine chemotherapeutic agents are two current critical considerations for tumor therapy. In this study, we report a reactive oxygen species (ROS)-activated yolk-shell nanoplatform for the tumor-specific co-delivery of cytochrome c (Cyt c) prodrug and doxorubicin, in which the bioactivity of Cyt c could be restored by the intracellular ROS-trigger and readily initiate the sequential doxorubicin release. The DOX-loaded lactobionic acid-modified yolk-shell mesoporous silica nanoparticles were first encapsulated with 4-nitrophenyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl carbonate (NBC)-modified Cyt c via boronic ester linkages, and functionalized again with lactobionic acid to further shield Cyt c and confer the selective tumor targeting against liver cancer cells. The key feature in this design is that by taking advantage of the boronic ester linkage, the cytotoxicity of Cyt c capped on the nanoparticle could be temporarily deactivated during blood transportation and rapidly restored upon exposure to the ROS-rich microenvironment within liver cancer cells, thereby simultaneously achieving the protein therapy and stimuli-responsive doxorubicin release. This study presents a novel strategy for the development of tumor-sensitive co-delivery nanoplatforms. |
WOS关键词 | MESOPOROUS SILICA NANOPARTICLES ; INTRACELLULAR PROTEIN DELIVERY ; CANCER-THERAPY ; HYDROGEN-PEROXIDE ; FLUORESCENT-PROBE ; DRUG-DELIVERY ; RELEASE ; PRODRUG ; NANOMEDICINE ; NANOCARRIERS |
资助项目 | National Natural Science Foundation of China[51602034] ; National Natural Science Foundation of China[51603024] ; National Key R&D Program of China[2016YFC1100300] ; National Key R&D Program of China[2017YFB0702600] ; China Postdoctoral Science Foundation[2017M612919] ; Innovation Project of the Common Key Technology of Chongqing Science and Technology Industry[cstc2015zdcy-ztzx120003] ; People's Livelihood Special Innovation Projects of Chongqing CSTC[cstc2017shmsA1089] ; Fundamental Research Funds for the Central Universities[10611CDJXZ238826] |
WOS研究方向 | Chemistry ; Science & Technology - Other Topics ; Materials Science ; Physics |
语种 | 英语 |
WOS记录号 | WOS:000436133400022 |
出版者 | ROYAL SOC CHEMISTRY |
资助机构 | National Natural Science Foundation of China ; National Key R&D Program of China ; China Postdoctoral Science Foundation ; Innovation Project of the Common Key Technology of Chongqing Science and Technology Industry ; People's Livelihood Special Innovation Projects of Chongqing CSTC ; Fundamental Research Funds for the Central Universities |
源URL | [http://ir.qibebt.ac.cn/handle/337004/12337] ![]() |
专题 | 中国科学院青岛生物能源与过程研究所 |
通讯作者 | Hu, Yan; Luo, Zhong; Cai, Kaiyong |
作者单位 | 1.Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China 2.Chongqing Univ, Sch Life Sci, Chongqing 400044, Peoples R China 3.Chongqing Med & Pharmaceut Coll, Chongqing Engn Res Ctr Pharmaceut Sci, Chongqing 401331, Peoples R China 4.Chinese Acad Sci, Inst Acoust, Qingdao Branch, Qingdao, Peoples R China |
推荐引用方式 GB/T 7714 | Pei, Yuxia,Li, Menghuan,Hou, Yanhua,et al. An autonomous tumor-targeted nanoprodrug for reactive oxygen species-activatable dual-cytochrome c/doxorubicin antitumor therapy[J]. NANOSCALE,2018,10(24):11418-11429. |
APA | Pei, Yuxia.,Li, Menghuan.,Hou, Yanhua.,Hu, Yan.,Chu, Guangyu.,...&Cai, Kaiyong.(2018).An autonomous tumor-targeted nanoprodrug for reactive oxygen species-activatable dual-cytochrome c/doxorubicin antitumor therapy.NANOSCALE,10(24),11418-11429. |
MLA | Pei, Yuxia,et al."An autonomous tumor-targeted nanoprodrug for reactive oxygen species-activatable dual-cytochrome c/doxorubicin antitumor therapy".NANOSCALE 10.24(2018):11418-11429. |
入库方式: OAI收割
来源:青岛生物能源与过程研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。